Type 2 Diabetes Market, By Drug Class (Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like peptide 1 receptor agonists, Biguanides, Sodium-glucose cotransporter 2 (SGLT2) inhibitors, and Others), By Route of Administration (Oral and Parenteral), By End User (Homecare Settings, Hospitals & Clinics, Academic & Research Institutes, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Select a license type that suits your business needs
Single User License
US$ 4,500
US$ 3,500
Three thousand five hundred dollars
Frequently purchased
Multi User License
US$ 7,000
US$ 5,500
Five thousand five hundred dollars
Corporate User License
US$ 10,000
US$ 7,500
Seven thousand five hundred dollars
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
JAPAN : 
INDIA :